Literature DB >> 17628225

MRI findings in pediatric ophthalmoplegic migraine: a case report and literature review.

Diana X Bharucha1, Timothy B Campbell, Ignacio Valencia, H Huntley Hardison, Sanjeev V Kothare.   

Abstract

Ophthalmoplegic migraine (also recognized as a cranial neuralgia) is a form of migraine characterized by recurrent episodes of headache with ophthalmoplegia related to paresis of cranial nerves III, IV, or VI, with onset typically in childhood. These symptomatic episodes may persist for several hours or for several weeks, months, or permanently. To date, the exact etiology of ophthalmoplegic migraine remains unknown. In previous case reports, ophthalmoplegic migraine may or may not be associated with changes seen on magnetic resonance imaging. Contrast-enhanced magnetic resonance imaging performed during symptomatic and postsymptomatic periods in patients with ophthalmoplegic migraine may hold great value in identifying the pathophysiologic features of oculomotor nerve palsies. Of cases demonstrating abnormal magnetic resonance imaging, a majority show improved but persistent changes on repeat imaging. The present report describes a case of recurrent ophthalmoplegic migraine in a 16-year-old girl. Although the patient presented with ophthalmoplegic migraine during this episode in the same manner as her prior episodes, enhancement of the cranial nerve III on magnetic resonance imaging was evident during the eighth episode whereas previous imaging had been normal. Complete resolution of enhancement of the oculomotor nerve on repeat imaging adds to the few cases that have shown such findings in patients with recurrent ophthalmoplegic migraine. A review of previous reported cases of ophthalmoplegic migraine is offered.

Entities:  

Mesh:

Year:  2007        PMID: 17628225     DOI: 10.1016/j.pediatrneurol.2007.03.008

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  17 in total

Review 1.  Ophthalmoplegic "migraine" or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review.

Authors:  Amy A Gelfand; Jeffrey M Gelfand; Prab Prabakhar; Peter J Goadsby
Journal:  J Child Neurol       Date:  2012-01-12       Impact factor: 1.987

2.  Chronic immune sensory polyradiculopathy with cranial and peripheral nerve involvement.

Authors:  S Anand Trip; Tabish Saifee; Will Honan; Hoskote Chandrashekar; Michael P Lunn; Tarek Yousry; Martin Koltzenburg; Mary M Reilly
Journal:  J Neurol       Date:  2011-11-29       Impact factor: 4.849

Review 3.  Orbital and anterior visual pathway infection and inflammation.

Authors:  Roel De Wyngaert; Ingele Casteels; Philippe Demaerel
Journal:  Neuroradiology       Date:  2009-02-17       Impact factor: 2.804

4.  Persistent focal enhancement of the cisternal segment of oculomotor nerve in ophthalmoplegic migraine.

Authors:  Ihtesham A Qureshi; Gustavo J Rodriguez; Salvador Cruz-Flores; Alberto Maud
Journal:  Neurol Clin Pract       Date:  2017-10

5.  Are some ophthalmoplegias migrainous in origin?

Authors:  Vivek Lal; Louis Caplan
Journal:  Neurol Clin Pract       Date:  2019-06

Review 6.  From ophthalmoplegic migraine to cranial neuropathy.

Authors:  Stefanie Förderreuther; Ruth Ruscheweyh
Journal:  Curr Pain Headache Rep       Date:  2015-06

Review 7.  Relapsing Painful Ophthalmoplegic Neuropathy: No longer a "Migraine," but Still a Headache.

Authors:  Stacy V Smith; Nathaniel M Schuster
Journal:  Curr Pain Headache Rep       Date:  2018-06-14

8.  Ophthalmoplegic migraine with isolated third cranial nerve palsy in a known case of juvenile myoclonic epilepsy.

Authors:  Aakash Shetty; Supriya Khardenavis; Anirudda Deshpande
Journal:  BMJ Case Rep       Date:  2013-12-02

Review 9.  Ophthalmoplegic migraine: still a diagnostic dilemma?

Authors:  K Ravishankar
Journal:  Curr Pain Headache Rep       Date:  2008-08

10.  Non-invasive near infrared fluorescence imaging of CdHgTe quantum dots in mouse model.

Authors:  Haiyan Chen; Yunqing Wang; Jing Xu; Jinzi Ji; Jian Zhang; Yuzhu Hu; Yueqing Gu
Journal:  J Fluoresc       Date:  2008-01-05       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.